அலெம்பிக் மருந்துகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அலெம்பிக் மருந்துகள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அலெம்பிக் மருந்துகள் இன்க் Today - Breaking & Trending Today

Sun Pharma, Alembic recall products in US market

Sun Pharma, Alembic recall products in US market
SECTIONS
Last Updated: Apr 18, 2021, 11:47 AM IST
Share
Synopsis
According to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.
According to the US regulator, a class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences .
Related
NSE
Explore Now
NEW DELHI: Leading drug makers Sun Pharma and Alembic Pharmaceuticals are recalling different products in the US, the world s largest market for medicines.
As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), US-based unit of Sun Pharma is recalling 91,211 pre-filled syringes of Ganirelix Acetate injection due to failed impurities/degradation specifications . ....

New Jersey , United States , Sun Pharma , Sun Pharma Halol , Ferring Pharmaceuticals Inc , Alembic Pharmaceuticals Inc , Alembic Pharmaceuticals , Drug Administration , Sun Pharmaceutical Industries Inc , Enforcement Report , Ganirelix Acetate , Acetate Injection , Telmisartan Tablets , புதியது ஜெர்சி , ஒன்றுபட்டது மாநிலங்களில் , சூரியன் பார்மா , சூரியன் பார்மா ஹலோல் , ஃபெர்ரிங் மருந்துகள் இன்க் , அலெம்பிக் மருந்துகள் இன்க் , அலெம்பிக் மருந்துகள் , சூரியன் மருந்து தொழில்கள் இன்க் , அமலாக்கம் அறிக்கை , அசிடேட் ஊசி ,

Premature Ejaculation Treatment Market to grow by USD 1.29 Billion and Record a CAGR of over 10%

Share this article
NEW YORK, April 14, 2021 /PRNewswire/
The premature ejaculation treatment market is set to grow by USD 1.29 billion, progressing at a CAGR of over 10% during 2021-2025. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
Technavio has announced its latest market research report titled Premature Ejaculation Treatment Market by Route of Administration, Drug Class, and Geography - Forecast and Analysis 2021-2025
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Bayer AG, Eli Lilly and Co., InvaGen Pharmaceuticals Inc., Pfizer Inc., Sandoz AG, Solco Healthcare, and Teva Pharmaceutical Industries Ltd. are some of the major market participants. The high efficacy of off-label drugs will offer immense growth opportun ....

United States , United Kingdom , Eli Lilly , Jesse Maida , Bayer Ag , Technavio Research , Amneal Pharmaceuticals Inc , Teva Pharmaceutical Industries Ltd , Alembic Pharmaceuticals Inc , Pfizer Inc , Absorption Pharmaceuticals , Health Care , Invagen Pharmaceuticals Inc , Route Of Administration , Solco Healthcare , Teva Pharmaceutical Industries , Ejaculation Treatment Market , Vendor Analysis , Health Care Include , Female Sexual Dysfunction Treatment , North America , Drug Class , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , எலி லில்லி , ஜெஸ்ஸி மைதா ,